Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer

The identification of biomarkers for predicting the responsiveness to eribulin in patients with metastatic breast cancer pretreated with an anthracycline and a taxane remains an unmet need. Here, we established a serum microRNA (miRNA)-based prediction model for the emergence of new distant metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Satomi-Tsushita, Natsuko, Shimomura, Akihiko, Matsuzaki, Juntaro, Yamamoto, Yusuke, Kawauchi, Junpei, Takizawa, Satoko, Aoki, Yoshiaki, Sakamoto, Hiromi, Kato, Ken, Shimizu, Chikako, Ochiya, Takahiro, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726239/
https://www.ncbi.nlm.nih.gov/pubmed/31483849
http://dx.doi.org/10.1371/journal.pone.0222024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726239/
https://www.ncbi.nlm.nih.gov/pubmed/31483849
http://dx.doi.org/10.1371/journal.pone.0222024

Ejemplares similares